As of 2025-10-30, the Intrinsic Value of Conmed Corp (CNMD) is 70.68 USD. This CNMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 46.71 USD, the upside of Conmed Corp is 51.30%.
The range of the Intrinsic Value is 48.24 - 115.94 USD
Based on its market price of 46.71 USD and our intrinsic valuation, Conmed Corp (CNMD) is undervalued by 51.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 48.24 - 115.94 | 70.68 | 51.3% |
| DCF (Growth 10y) | 58.00 - 125.11 | 80.42 | 72.2% |
| DCF (EBITDA 5y) | 57.28 - 75.90 | 61.84 | 32.4% |
| DCF (EBITDA 10y) | 65.90 - 89.84 | 73.32 | 57.0% |
| Fair Value | 89.01 - 89.01 | 89.01 | 90.56% |
| P/E | 65.19 - 169.12 | 102.73 | 119.9% |
| EV/EBITDA | 63.08 - 105.80 | 81.98 | 75.5% |
| EPV | 69.06 - 94.88 | 81.97 | 75.5% |
| DDM - Stable | 24.36 - 55.18 | 39.77 | -14.9% |
| DDM - Multi | 37.63 - 65.12 | 47.59 | 1.9% |
| Market Cap (mil) | 1,445.67 |
| Beta | 0.69 |
| Outstanding shares (mil) | 30.95 |
| Enterprise Value (mil) | 2,293.56 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.02% |
| Cost of Debt | 4.54% |
| WACC | 7.62% |